# Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

> **NCT03036930** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 51 (actual)

## Conditions studied

- Human Papillomavirus Infection
- Human Papillomavirus-Related Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** HPV Self-Collection
- **OTHER:** Questionnaire Administration
- **BIOLOGICAL:** Recombinant Human Papillomavirus Nonavalent Vaccine

## Key facts

- **NCT ID:** NCT03036930
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-06-23
- **Primary completion:** 2024-03-04
- **Final completion:** 2027-03-10
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036930, "Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03036930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*